Cargando…

Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak

BACKGROUND AND AIM: Sars-CoV-2 infection has rapidly spread worldwide following the first cases reported in China. Piacenza is one of the most affected cities in Italy. Many infections occurred in the hospital due to the high frequency of patients and healthcare professionals interaction. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossi, Elena, Agnoli, Benedetta, Baldini, Monica, Illari, Simona, Bonini, Renza, Scagnelli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138813/
https://www.ncbi.nlm.nih.gov/pubmed/33855978
http://dx.doi.org/10.23750/abm.v92iS2.11320
_version_ 1783695883319115776
author Grossi, Elena
Agnoli, Benedetta
Baldini, Monica
Illari, Simona
Bonini, Renza
Scagnelli, Giuseppe
author_facet Grossi, Elena
Agnoli, Benedetta
Baldini, Monica
Illari, Simona
Bonini, Renza
Scagnelli, Giuseppe
author_sort Grossi, Elena
collection PubMed
description BACKGROUND AND AIM: Sars-CoV-2 infection has rapidly spread worldwide following the first cases reported in China. Piacenza is one of the most affected cities in Italy. Many infections occurred in the hospital due to the high frequency of patients and healthcare professionals interaction. The aim of the work is to evaluate advantages of universal screening for Sars-Cov-2 in pregnant women admitted to a hospital setting and calculate frequency of infection in an obstetrical population. METHODS: all pregnant women attending Guglielmo da Saliceto Hospital in Piacenza from 22nd April to 18th June 2020 were screened for Sars-Cov-2 using a nasopharyngeal swab. RESULTS: 240 pregnant women were tested upon admission: all twelve (5%) testing positive were asymptomatic. None of the positive asymptomatic women developed COVID-19 symptoms or adverse perinatal outcomes. CONCLUSIONS: the diagnosis of asymptomatic pregnant women through universal screening provides the opportunity to protect mothers, babies and heath care workers. In accordance with other studies, our findings add to the growing body of evidence showing high rates of asymptomatic infection in the healthcare setting and highlight a critical need for universal screening of pregnant women. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-8138813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-81388132021-05-26 Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak Grossi, Elena Agnoli, Benedetta Baldini, Monica Illari, Simona Bonini, Renza Scagnelli, Giuseppe Acta Biomed Original Article: Covid-19 and Health Professionals BACKGROUND AND AIM: Sars-CoV-2 infection has rapidly spread worldwide following the first cases reported in China. Piacenza is one of the most affected cities in Italy. Many infections occurred in the hospital due to the high frequency of patients and healthcare professionals interaction. The aim of the work is to evaluate advantages of universal screening for Sars-Cov-2 in pregnant women admitted to a hospital setting and calculate frequency of infection in an obstetrical population. METHODS: all pregnant women attending Guglielmo da Saliceto Hospital in Piacenza from 22nd April to 18th June 2020 were screened for Sars-Cov-2 using a nasopharyngeal swab. RESULTS: 240 pregnant women were tested upon admission: all twelve (5%) testing positive were asymptomatic. None of the positive asymptomatic women developed COVID-19 symptoms or adverse perinatal outcomes. CONCLUSIONS: the diagnosis of asymptomatic pregnant women through universal screening provides the opportunity to protect mothers, babies and heath care workers. In accordance with other studies, our findings add to the growing body of evidence showing high rates of asymptomatic infection in the healthcare setting and highlight a critical need for universal screening of pregnant women. (www.actabiomedica.it) Mattioli 1885 2021 2021-03-31 /pmc/articles/PMC8138813/ /pubmed/33855978 http://dx.doi.org/10.23750/abm.v92iS2.11320 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article: Covid-19 and Health Professionals
Grossi, Elena
Agnoli, Benedetta
Baldini, Monica
Illari, Simona
Bonini, Renza
Scagnelli, Giuseppe
Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak
title Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak
title_full Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak
title_fullStr Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak
title_full_unstemmed Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak
title_short Universal SARS-CoV-2 screening in pregnant women: experience from the Italian epidemic outbreak
title_sort universal sars-cov-2 screening in pregnant women: experience from the italian epidemic outbreak
topic Original Article: Covid-19 and Health Professionals
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138813/
https://www.ncbi.nlm.nih.gov/pubmed/33855978
http://dx.doi.org/10.23750/abm.v92iS2.11320
work_keys_str_mv AT grossielena universalsarscov2screeninginpregnantwomenexperiencefromtheitalianepidemicoutbreak
AT agnolibenedetta universalsarscov2screeninginpregnantwomenexperiencefromtheitalianepidemicoutbreak
AT baldinimonica universalsarscov2screeninginpregnantwomenexperiencefromtheitalianepidemicoutbreak
AT illarisimona universalsarscov2screeninginpregnantwomenexperiencefromtheitalianepidemicoutbreak
AT boninirenza universalsarscov2screeninginpregnantwomenexperiencefromtheitalianepidemicoutbreak
AT scagnelligiuseppe universalsarscov2screeninginpregnantwomenexperiencefromtheitalianepidemicoutbreak